Trial Outcomes & Findings for Comparison of Coagulation Factors During Laparoscopic Cholecystectomy (NCT NCT02568852)

NCT ID: NCT02568852

Last Updated: 2016-06-30

Results Overview

group1 and group 2(Duration of Operation)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

up to 2 hours

Results posted on

2016-06-30

Participant Flow

Participant milestones

Participant milestones
Measure
Group 1
Laparoscopic cholecystectomy under general anaesthesia
Group 2
Laparoscopic cholecystectomy under combined anaesthesia (Spino epidural).
Overall Study
STARTED
25
25
Overall Study
COMPLETED
25
25
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Comparison of Coagulation Factors During Laparoscopic Cholecystectomy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in under 10 mmHg pneumoperitoneum
Group 2
n=25 Participants
Laparoscopic cholecystectomy in under 14 mmHg pneumoperitoneum
Total
n=50 Participants
Total of all reporting groups
Age, Continuous
46 years
n=5 Participants
52 years
n=7 Participants
48 years
n=5 Participants
Sex: Female, Male
Female
20 Participants
n=5 Participants
19 Participants
n=7 Participants
39 Participants
n=5 Participants
Sex: Female, Male
Male
5 Participants
n=5 Participants
6 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
Turkey
25 participants
n=5 Participants
25 participants
n=7 Participants
50 participants
n=5 Participants
ASA(American Society of Anesthesiologists ) scores
1 Scores on a scale(min:1 and max:6)
n=5 Participants
2 Scores on a scale(min:1 and max:6)
n=7 Participants
2 Scores on a scale(min:1 and max:6)
n=5 Participants
BMI
28.1 kg/m^2
STANDARD_DEVIATION 4.0 • n=5 Participants
28.2 kg/m^2
STANDARD_DEVIATION 3.5 • n=7 Participants
28.15 kg/m^2
STANDARD_DEVIATION 3.72 • n=5 Participants

PRIMARY outcome

Timeframe: up to 2 hours

Population: All patients have gall bladder disease who are between 18-80 years old.

group1 and group 2(Duration of Operation)

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
Duration of Operation
54 minutes
Interval 45.0 to 80.0
65 minutes
Interval 53.0 to 92.0

SECONDARY outcome

Timeframe: pre-operative

Population: All patients have gall bladder disease who are between 18-80 years old.

A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
Fibrinogen Level
219 mg/dL
Interval 138.0 to 318.0
261 mg/dL
Interval 87.0 to 395.0

SECONDARY outcome

Timeframe: Post-operative 1 st hour

Population: All patients have gall bladder disease who are between 18-80 years old.

A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
Fibrinogen Level
253 mg/dL
Interval 214.0 to 382.0
320 mg/dL
Interval 171.0 to 495.0

SECONDARY outcome

Timeframe: Post-operative 24th hour

Population: All patients have gall bladder disease who are between 18-80 years old.

A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
Fibrinogen Level
352 mg/dL
Interval 258.0 to 496.0
421 mg/dL
Interval 250.0 to 760.0

SECONDARY outcome

Timeframe: pre-operative

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the extrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
PT(Prothrombin Time)
11.94 seconds
Standard Deviation 0.64
11.78 seconds
Standard Deviation 0.75

SECONDARY outcome

Timeframe: Post-operative 1st hour

measures of the extrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
PT(Prothrombin Time)
12.1 seconds
Standard Deviation 0.53
12.69 seconds
Standard Deviation 0.84

SECONDARY outcome

Timeframe: Post-operative 24th hours

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the extrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
PT(Prothrombin Time)
12.43 seconds
Standard Deviation 0.86
13.63 seconds
Standard Deviation 1.07

SECONDARY outcome

Timeframe: pre-operative

Population: All patients have gall bladder disease who are between 18-80 years old.

A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
D-Dimer
0.31 mg/L
Standard Deviation 0.08
0.34 mg/L
Standard Deviation 0.10

SECONDARY outcome

Timeframe: Post-operative 1st hour

Population: All patients have gall bladder disease who are between 18-80 years old.

A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
D-Dimer
0.56 mg/L
Standard Deviation 0.22
1.06 mg/L
Standard Deviation 0.7

SECONDARY outcome

Timeframe: Post-operative 24th hours

Population: All patients have gall bladder disease who are between 18-80 years old.

A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
D-Dimer
0.91 mg/L
Standard Deviation 0.34
1.61 mg/L
Standard Deviation 0.95

SECONDARY outcome

Timeframe: pre-operative

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the intrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
aPTT(Activated Partial Thromboplastin Time)
22.80 seconds
Standard Deviation 1.48
25.0 seconds
Standard Deviation 2.86

SECONDARY outcome

Timeframe: Post-operative 1st hour

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the intrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
aPTT(Activated Partial Thromboplastin Time)
23.42 seconds
Standard Deviation 1.54
25.25 seconds
Standard Deviation 2.35

SECONDARY outcome

Timeframe: Post-operative 24th hours

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the intrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
aPTT(Activated Partial Thromboplastin Time)
24.54 seconds
Standard Deviation 2.16
26.92 seconds
Standard Deviation 2.92

SECONDARY outcome

Timeframe: pre-operative

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the extrinsic and intrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
Thrombin Time(TT)
19.88 seconds
Standard Deviation 1.58
20.57 seconds
Standard Deviation 2.12

SECONDARY outcome

Timeframe: Post-operative 1st hour

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the extrinsic and intrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
Thrombin Time(TT)
17.78 seconds
Standard Deviation 0.74
17.61 seconds
Standard Deviation 1.02

SECONDARY outcome

Timeframe: Post-operative 24th hours

Population: All patients have gall bladder disease who are between 18-80 years old.

measures of the extrinsic and intrinsic pathway of coagulation

Outcome measures

Outcome measures
Measure
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural). General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
Thrombin Time(TT)
16.06 seconds
Standard Deviation 1.05
16.01 seconds
Standard Deviation 0.72

Adverse Events

Group 1

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Group 2

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Group 1
n=25 participants at risk
Laparoscopic cholecystectomy in under general anaesthesia.(10 mmHg CO2 pneumoperitoneum)
Group 2
n=25 participants at risk
Laparoscopic cholecystectomy in under spinal epidural anaesthesia.(10 mmHg CO2 pneumoperitoneum)
Cardiac disorders
Hypotension
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
8.0%
2/25 • Number of events 2 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
Renal and urinary disorders
urinary retension
0.00%
0/25 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
Gastrointestinal disorders
Nausea/vomiting
16.0%
4/25 • Number of events 4 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
Nervous system disorders
headache
0.00%
0/25 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.

Additional Information

Dr.Turgut Donmez

Haseki-156

Phone: 00905347400967

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place